MiNK Therapeutics, Inc. (INKT)
NASDAQ: INKT · Real-Time Price · USD
11.78
-0.47 (-3.84%)
At close: Jan 30, 2026, 4:00 PM EST
11.85
+0.07 (0.59%)
After-hours: Jan 30, 2026, 6:19 PM EST

MiNK Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
14.284.583.3719.6438.892.69
Cash & Short-Term Investments
14.284.583.3719.6438.892.69
Cash Growth
125.67%35.93%-82.85%-49.51%1345.06%799.94%
Other Receivables
-----0.25
Receivables
-----0.25
Prepaid Expenses
0.250.250.050.300.49
Other Current Assets
00.160.180.470.740.66
Total Current Assets
14.534.993.620.439.634.1
Property, Plant & Equipment
0.430.730.951.070.610.46
Total Assets
14.965.724.5521.4740.244.56
Accounts Payable
3.692.733.915.8233.14
Accrued Expenses
1.261.875.044.241.761.86
Other Current Liabilities
2.762.362.452.6211.719.22
Total Current Liabilities
13.436.9611.412.6816.4714.22
Long-Term Debt
-4.92---43.82
Other Long-Term Liabilities
15.0413.4211.219.19-0.38
Total Liabilities
28.4825.3122.6121.8716.4758.43
Common Stock
000000
Additional Paid-In Capital
141.25125.23115.77110.83107.350.38
Retained Earnings
-154.07-144.18-133.4-110.94-82.95-52.74
Comprehensive Income & Other
-0.69-0.63-0.43-0.29-0.63-1.52
Shareholders' Equity
-13.51-19.59-18.06-0.423.78-53.87
Total Liabilities & Equity
14.965.724.5521.4740.244.56
Total Debt
5.734.92---43.82
Net Cash (Debt)
8.56-0.353.3719.6438.89-41.13
Net Cash Growth
398.43%--82.85%-49.51%--
Net Cash Per Share
2.09-0.090.985.8314.94-17.06
Filing Date Shares Outstanding
4.693.973.473.393.362.42
Total Common Shares Outstanding
4.63.963.463.393.352.42
Working Capital
1.1-1.97-7.87.7223.17-10.13
Book Value Per Share
-2.94-4.94-5.22-0.127.10-22.28
Tangible Book Value
-13.51-19.59-18.06-0.423.78-53.87
Tangible Book Value Per Share
-2.94-4.94-5.22-0.127.10-22.28
Machinery
11.261.451.350.780.56
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q